Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
Orthopade ; 49(1): 1-9, 2020 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-30937490

RESUMEN

BACKGROUND: The symptoms of muscle weakness, bone pain and fragility fractures can be an indication of osteomalacia. Phosphate is often not considered within osteologic parameters, decreased levels are therefore easily overseen. The additional test for fibroblast growth factor 23 (FGF23) as indicator for tumor-induced osteomalacia (TIO) is still largely unfamiliar. OBJECTIVE: By emphasizing the role of phosphate and furthermore FGF23 in bone metabolism illustrated by the long-term disease process of our clinical case we would like to introduce these parameters to a broader public. METHODS: We performed a literature search via PubMed and Google Scholar with the relevant key words and summarized the diagnostic and therapeutic information. The studies evaluated were mainly case reports. We present a case report of a 70-year-old patient with TIO and a myopericytoma and retrospectively analyzed the clinical case. The follow-up was 6 months. RESULTS: Our literature search found one case of TIO and evidence of FGF23 among 124 cases of myopericytomas in total. Over 300 cases of TIO are reported. In our case, we retrospectively found an FGF23-secreting myopericytoma in the phosphaturic mesenchymal tumors (PMT) group to be the cause of pseudarthrosis on the right humerus shaft and increasing disablement in a patient with osteomalacia. After surgical resection the patient was mobile again, and the osteologic parameters, especially phosphate, normalized from 0.21 to 1.52 mmol/l. CONCLUSION: Low phosphate levels are the decisive indication of TIO in our case. Therefore, we should always think of phosphate level control when dealing with osteomalacia. A hypophosphatemia and hyperphosphaturia should be recognized in time and be diagnostically verified. The additional FGF23 test (c-terminal and intact FGF23) should be considered.


Asunto(s)
Factores de Crecimiento de Fibroblastos/metabolismo , Myopericytoma/metabolismo , Neoplasias de Tejido Conjuntivo , Osteomalacia , Anciano , Factor-23 de Crecimiento de Fibroblastos , Humanos , Síndromes Paraneoplásicos , Estudios Retrospectivos
2.
Unfallchirurg ; 123(8): 653-658, 2020 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-32347369

RESUMEN

This article reports a case of medial dislocation of the talus as a rare injury caused by a fall from a low height.Treatment recommendations given in the literature for this rare injury are heterogeneous but closed reduction is predominant. Little is known about possible obstacles in closed reduction. The known complications include posttraumatic arthritis and necrosis of the talus.A posttraumatic lesion of the tibial nerve has not been reported, which is why a treatment recommendation is illustrated and discussed based on this case report.


Asunto(s)
Luxaciones Articulares , Astrágalo , Nervio Tibial , Accidentes por Caídas , Humanos , Luxaciones Articulares/complicaciones , Astrágalo/lesiones , Nervio Tibial/lesiones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA